Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s disease

Abstract Discoidin Domain Receptor (DDR)-1 is activated by collagen. Nilotinib is a tyrosine kinase inhibitor that is FDA-approved for leukemia and potently inhibits DDR-1. Individuals diagnosed with mild–moderate Alzheimer’s disease (AD) treated with nilotinib (versus placebo) for 12 months showed...

全面介紹

書目詳細資料

Principais autores:	Max Stevenson, Rency Varghese, Michaeline L. Hebron, Xiaoguang Liu, Nick Ratliff, Amelia Smith, R. Scott Turner, Charbel Moussa
格式:	Artigo
語言:	Inglês
出版:	BMC 2023-05-01
叢編:	Journal of Neuroinflammation
主題:	Discoidin domain receptor 1 Alzheimer’s disease MicroRNAs Collagen Nilotinib Cytokines
在線閱讀:	https://doi.org/10.1186/s12974-023-02802-0
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!